Abstract:PurposeThe 5 year overall survival (OS) for Glioblastoma multiforme (GBM) remains low.Our cohort had a lower percentage completing adjuvant treatment than those reported in trials. We assess those not completing planned 6 cycles of adjuvant treatment.We assess survival data for those who had Gliadel wafer insertion at the time of primary surgery. We go on to assess the combination of these factors on survival.MethodsCohort of 110 patients who had undergone neurosurgery followed by chemo-radiotherapy (CRT) 60 G… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.